A Long-Read RNA-Seq Approach to Identify Novel Transcripts of Very Large Genes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Assembly and Maintenance of Sarcomere Thin Filaments and Associated Diseases
International Journal of Molecular Sciences Review Assembly and Maintenance of Sarcomere Thin Filaments and Associated Diseases Kendal Prill and John F. Dawson * Centre for Cardiovascular Investigations, Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON N1G 2W1, Canada; [email protected] * Correspondence: [email protected] Received: 17 December 2019; Accepted: 12 January 2020; Published: 15 January 2020 Abstract: Sarcomere assembly and maintenance are essential physiological processes required for cardiac and skeletal muscle function and organism mobility. Over decades of research, components of the sarcomere and factors involved in the formation and maintenance of this contractile unit have been identified. Although we have a general understanding of sarcomere assembly and maintenance, much less is known about the development of the thin filaments and associated factors within the sarcomere. In the last decade, advancements in medical intervention and genome sequencing have uncovered patients with novel mutations in sarcomere thin filaments. Pairing this sequencing with reverse genetics and the ability to generate patient avatars in model organisms has begun to deepen our understanding of sarcomere thin filament development. In this review, we provide a summary of recent findings regarding sarcomere assembly, maintenance, and disease with respect to thin filaments, building on the previous knowledge in the field. We highlight debated and unknown areas within these processes to clearly define open research questions. Keywords: sarcomere assembly; sarcomere maintenance; sarcomere thin filaments; thin filament assembly; thin filament maintenance; thin filament turnover; actin turnover; chaperone; sarcomere; myopathy 1. Introduction Striated muscle requires the coordination of hundreds of proteins not only for cellular function but also for assembly of the contractile sarcomere units within the myofibril. -
Compound Heterozygosity for Novel Truncating Variants in the LMOD3 Gene As the Cause of Polyhydramnios in Two Successive Fetuses
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Online Research @ Cardiff CASE REPORT published: 13 September 2019 doi: 10.3389/fgene.2019.00835 Compound Heterozygosity for Novel Truncating Variants in the LMOD3 Gene as the Cause of Polyhydramnios in Two Successive Fetuses Ye Wang 1, Caixia Zhu 1, Liu Du 2, Qiaoer Li 3, Mei-Fang Lin 2, Claude Férec 4,5, David N. Cooper 6, Jian-Min Chen 4† and Yi Zhou 1*† 1 Fetal Medicine Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China, 2 Department of Ultrasonic Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China, 3 Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-Sen University, Jiangmen, China, 4 EFS, Univ Brest, Inserm, UMR 1078, GGB, Brest, France, 5 CHU Brest, Service de Génétique, Brest, France, 6Institute of Medical Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom Polyhydramnios is sometimes associated with genetic defects. However, establishing an Edited by: Fan Jin, accurate diagnosis and pinpointing the precise genetic cause of polyhydramnios in any Zhejiang University, China given case represents a major challenge because it is known to occur in association with Reviewed by: over 200 different conditions. Whole exome sequencing (WES) is now a routine part of Liang-Liang Fan, Central South University, China the clinical workup, particularly with diseases characterized by atypical manifestations and Wenbin Zou, significant genetic heterogeneity. Here we describe the identification, by means of WES, Changhai Hospital, China of novel compound heterozygous truncating variants in the LMOD3 gene [i.e., c.1412delA *Correspondence: (p.Lys471Serfs*18) and c.1283dupC (p.Gly429Trpfs*35)] in a Chinese family with two Yi Zhou [email protected] successive fetuses affected with polyhydramnios, thereby potentiating the prenatal diagnosis of nemaline myopathy (NM) in the proband. -
Stockholm University
Stockholm University This is a published version of a paper published in Journal of Molecular Biology. Citation for the published paper: Björklund, Å., Light, S., Sagit, R., Elofsson, A. (2010) "Nebulin: A Study of Protein Repeat Evolution" Journal of Molecular Biology, 402(1): 38-51 URL: http://dx.doi.org/10.1016/j.jmb.2010.07.011 Access to the published version may require subscription. Permanent link to this version: http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-50177 http://su.diva-portal.org RGR YJMBI-62434; No. of pages: 14; 4C: 2, 5, 8, 9 doi:10.1016/j.jmb.2010.07.011 J. Mol. Biol. (2010) xx, xxx–xxx Available online at www.sciencedirect.com Nebulin: A Study of Protein Repeat Evolution Åsa K. Björklund, Sara Light†, Rauan Sagit† and Arne Elofsson⁎ Center for Biological Membrane Protein domain repeats are common in proteins that are central to the Research, Stockholm organization of a cell, in particular in eukaryotes. They are known to evolve Bioinformatics Center, through internal tandem duplications. However, the understanding of the Department of Biochemistry and underlying mechanisms is incomplete. To shed light on repeat expansion Biophysics, Stockholm mechanisms, we have studied the evolution of the muscle protein Nebulin, University, Stockholm, Sweden a protein that contains a large number of actin-binding nebulin domains. Nebulin proteins have evolved from an invertebrate precursor containing Received 30 March 2010; two nebulin domains. Repeat regions have expanded through duplications received in revised form of single domains, as well as duplications of a super repeat (SR) consisting 22 June 2010; of seven nebulins. -
2020 Program Book
PROGRAM BOOK Note that TAGC was cancelled and held online with a different schedule and program. This document serves as a record of the original program designed for the in-person meeting. April 22–26, 2020 Gaylord National Resort & Convention Center Metro Washington, DC TABLE OF CONTENTS About the GSA ........................................................................................................................................................ 3 Conference Organizers ...........................................................................................................................................4 General Information ...............................................................................................................................................7 Mobile App ....................................................................................................................................................7 Registration, Badges, and Pre-ordered T-shirts .............................................................................................7 Oral Presenters: Speaker Ready Room - Camellia 4.......................................................................................7 Poster Sessions and Exhibits - Prince George’s Exhibition Hall ......................................................................7 GSA Central - Booth 520 ................................................................................................................................8 Internet Access ..............................................................................................................................................8 -
Cardiomyopathy Precision Panel Overview Indications
Cardiomyopathy Precision Panel Overview Cardiomyopathies are a group of conditions with a strong genetic background that structurally hinder the heart to pump out blood to the rest of the body due to weakness in the heart muscles. These diseases affect individuals of all ages and can lead to heart failure and sudden cardiac death. If there is a family history of cardiomyopathy it is strongly recommended to undergo genetic testing to be aware of the family risk, personal risk, and treatment options. Most types of cardiomyopathies are inherited in a dominant manner, which means that one altered copy of the gene is enough for the disease to present in an individual. The symptoms of cardiomyopathy are variable, and these diseases can present in different ways. There are 5 types of cardiomyopathies, the most common being hypertrophic cardiomyopathy: 1. Hypertrophic cardiomyopathy (HCM) 2. Dilated cardiomyopathy (DCM) 3. Restrictive cardiomyopathy (RCM) 4. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) 5. Isolated Left Ventricular Non-Compaction Cardiomyopathy (LVNC). The Igenomix Cardiomyopathy Precision Panel serves as a diagnostic and tool ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes. Indications The Igenomix Cardiomyopathy Precision Panel is indicated in those cases where there is a clinical suspicion of cardiomyopathy with or without the following manifestations: - Shortness of breath - Fatigue - Arrythmia (abnormal heart rhythm) - Family history of arrhythmia - Abnormal scans - Ventricular tachycardia - Ventricular fibrillation - Chest Pain - Dizziness - Sudden cardiac death in the family 1 Clinical Utility The clinical utility of this panel is: - The genetic and molecular diagnosis for an accurate clinical diagnosis of a patient with personal or family history of cardiomyopathy, channelopathy or sudden cardiac death. -
1 Demographic History, Cold Adaptation, and Recent NRAP Recurrent Convergent Evolution At
bioRxiv preprint doi: https://doi.org/10.1101/2020.06.15.151894; this version posted June 15, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Demographic history, cold adaptation, and recent NRAP recurrent convergent evolution at 2 amino acid residue 100 in the world northernmost cattle from Russia 3 4 Laura Buggiotti1, Andrey A. Yurchenko2, Nikolay S. Yudin2, Christy J. Vander Jagt3, Hans D. 5 Daetwyler3,4, Denis M. Larkin1,2,5 6 1Royal Veterinary College, University of London, London, UK. 7 2The Federal State Budgetary Institution of Science Federal Research Center Institute of Cytology 8 and Genetics, Siberian Branch of the Russian Academy of Sciences (ICG SB RAS), Novosibirsk, 9 Russia. 10 3Agriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, 3083, Victoria, Australia. 11 4School of Applied Systems Biology, La Trobe University, Bundoora, 3083, Victoria, Australia. 12 5Kurchatov Genomics Center, the Federal Research Center Institute of Cytology and Genetics, 13 Siberian Branch of the Russian Academy of Science, Novosibirsk, Russia. 14 15 Abstract 16 Native cattle breeds represent an important cultural heritage. They are a reservoir of genetic variation 17 useful for properly responding to agriculture needs in light of ongoing climate changes. Evolutionary 18 processes that occur in response to extreme environmental conditions could also be better understood 19 using adapted local populations. Herein, different evolutionary histories for two of the world 20 northernmost native cattle breeds from Russia were investigated. They highlighted Kholmogory as a 21 typical taurine cattle, while Yakut cattle separated from European taurines ~5,000 years ago and 22 contain numerous ancestral and some novel genetic variants allowing their adaptation to harsh 23 conditions of living above the Polar Circle. -
The Functional Role of NRAP in the Nucleolus
The Functional Role of NRAP in the Nucleolus Author Inder, Kerry Published 2006 Thesis Type Thesis (PhD Doctorate) School School of Biomolecular and Biomedical Sciences DOI https://doi.org/10.25904/1912/3452 Copyright Statement The author owns the copyright in this thesis, unless stated otherwise. Downloaded from http://hdl.handle.net/10072/367738 Griffith Research Online https://research-repository.griffith.edu.au THE FUNCTIONAL ROLE OF NRAP IN THE NUCLEOLUS Presented by Kerry Inder, B Biomed Sci. (Hons) A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy School of Biomolecular and Biomedical Science And Natural Product Discovery Faculty of Science, Griffith University, Brisbane, Australia Submitted March, 2006 I STATEMENT OF ORIGINALITY The material presented in this thesis has not previously been submitted for a degree in any university. To the best of my knowledge and belief, the thesis contains no material previously published or written by another person except where due reference is made in the thesis itself. Kerry Inder. II PUBLICATIONS AND ABSTRACTS ARISING FROM THIS STUDY PUBLICATIONS Inder, K.L., Utama, B., Gan, Y., Wang, X., and Kennedy, D. Nrap/Nol6 is involved in rRNA processing through the regulation of B23/NPM and p19ARF. (submitted) ABSTRACTS Inder, K.L., Utama, B., Gan, Y., Wang, X., and Kennedy, D. Nrap/Nol6 is involved in rRNA processing through the regulation of B23/NPM and p19ARF., ComBio Combined Conference, Adelaide, Australia, 2005. (oral presentation) Hartmann, B., Aitken, K.L., Utama, B., Kennedy, D. Nrap, a novel nucleolar protein which interacts with B23/Nucleophosmin during ribosome biogenesis. -
RENAL TUMOURS to Be Used in Conjunction with the Umbrella Study Protocol
CLINICAL MANAGEMENT GUIDELINES RENAL TUMOURS To be used in conjunction with the Umbrella Study Protocol Dr Sucheta J Vaidya Dr Lisa Howell Dr Tanzina Chowdhury Dr Minou Oostveen Dr Cat Duncan Mr Mark Powis Mr Bruce Okoye Dr Daniel Saunders Professor Gordan Vujanic Professor Kathy Pritchard Jones On behalf of the CCLG Renal Tumour Special Interest Group January 2020 The CCLG does not sponsor or indemnify the treatment detailed herein. These treatment recommendations are provided by the CCLG Renal Tumours Special Interest Group to inform and for use at the sole discretion of treating clinicians who retain professional responsibility for their actions and treatment decisions. Treatment recommendations are based on current best practice and not what is necessarily proposed for any forthcoming clinical trial. CCLG Clinical Management Guidelines: Renal Tumours - January 2020 1 [This page is blank on purpose] CCLG Clinical Management Guidelines: Renal Tumours - January 2020 2 TABLE OF CONTENTS 1. Background and Rationale ............................................................................................. 8 2. Specific Objectives of CCLG Clinical Guidelines ............................................................. 10 3. Guideline Recommendations ....................................................................................... 10 3.1 Diagnostic work up guidelines for renal tumours ................................................................. 10 Clinical work-up .......................................................................................................................................... -
A Systems-Wide Screen Identifies Substrates of the SCF Ubiquitin Ligase
RESEARCH RESOURCE PROTEOMICS A systems-wide screen identifies substrates of the SCFbTrCP ubiquitin ligase Teck Yew Low,1,2 Mao Peng,1,2* Roberto Magliozzi,3* Shabaz Mohammed,1,2† Daniele Guardavaccaro,3 Albert J. R. Heck1,2‡ Cellular proteins are degraded by the ubiquitin-proteasome system (UPS) in a precise and timely fashion. Such precision is conferred by the high substrate specificity of ubiquitin ligases. Identification of substrates of ubiquitin ligases is crucial not only to unravel the molecular mechanisms by which the UPS controls protein degradation but also for drug discovery purposes because many established UPS substrates are implicated in disease. We developed a combined bioinformatics and affinity purification– mass spectrometry (AP-MS) workflow for the system-wide identification of substrates of SCFbTrCP,a member of the SCF family of ubiquitin ligases. These ubiquitin ligases are characterized by a multi- subunit architecture typically consisting of the invariable subunits Rbx1, Cul1, and Skp1, and one of 69 F-box proteins. The F-box protein of this member of the family is bTrCP. SCFbTrCP binds, through the WD40 b repeats of TrCP, to the DpSGXX(X)pS diphosphorylated motif in its substrates. We recovered 27 pre- Downloaded from viously reported SCFbTrCP substrates, of which 22 were verified by two independent statistical proto- cols, thereby confirming the reliability of this approach. In addition to known substrates, we identified 221 proteins that contained the DpSGXX(X)pS motif and also interacted specifically with the WD40 repeats of bTrCP. Thus, with SCFbTrCP, as the example, we showed that integration of structural infor- mation, AP-MS, and degron motif mining constitutes an effective method to screen for substrates of ubiquitin ligases. -
SELECTIVE REGULATION of BMP4 SIGNALING by the RECEPTOR TYROSINE KINASE Musk
SELECTIVE REGULATION OF BMP4 SIGNALING BY THE RECEPTOR TYROSINE KINASE MuSK ATILGAN YILMAZ B.S. MOLECULAR BIOLOGY AND GENETICS, BOĞAZİÇİ UNIVERSITY, 2005 A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN THE DIVISION OF BIOLOGY AND MEDICINE AT BROWN UNIVERSITY PROVIDENCE, RHODE ISLAND May 2013 i Copyright© 2012 by AtılgAn Yılmaz ii This dissertAtion by AtılgAn Yılmaz is accepted in its present form by the Division of Biology And Medicine, DepArtment of MoleculAr Biology, Cell Biology And Biochemistry As sAtisfying the dissertAtion requirement for the degree of Doctor of Philosophy. Date_____________ __________________________________ Dr. Justin R. Fallon, Advisor Recommended to the GrAduAte Council Date_____________ __________________________________ Dr. Kristi Wharton, Reader (ChAirman) Date_____________ __________________________________ Dr. GilAd BArnea, Reader Date_____________ __________________________________ Dr. Mark Zervas, Reader Date_____________ __________________________________ Dr. Steven Burden, Outside Reader Approved by the GrAduAte Council Date_____________ __________________________________ Dr. Peter Weber, Dean of the GraduAte School iii ATILGAN YILMAZ DOB: November 21, 1982 Mailing Address: DepArtment of Neuroscience, Brown University, Box G-LN 185 Meeting Street, Providence, RI 02912 Phone: 401 919 7262 E-mail: [email protected] EDUCATION Ph.D. in MoleculAr Biology, CellulAr Biology And Biochemistry (expected) Summer 2012 Brown University, Providence, RI Thesis: “Selective regulAtion of BMP4 signAling by the receptor tyrosine kinAse MuSK” B.S. in MoleculAr Biology And Genetics June 2005 Bogazici University, IstAnbul, Turkey, with Honors RESEARCH EXPERIENCE 04/06 – Graduate Student, Brown University, Providence, USA Selective regulation of BMP4 signaling by the receptor tyrosine kinase MuSK Advisor: Prof. Justin Fallon, DepArtment of Neuroscience 06/04 – 09/04 Undergraduate Summer Research Trainee. -
Loss of LMOD1 Impairs Smooth Muscle Cytocontractility And
Loss of LMOD1 impairs smooth muscle cytocontractility PNAS PLUS and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice Danny Halima,1, Michael P. Wilsonb,1, Daniel Oliverc, Erwin Brosensa, Joke B. G. M. Verheijd, Yu Hanb, Vivek Nandab, Qing Lyub, Michael Doukase, Hans Stoope, Rutger W. W. Brouwerf, Wilfred F. J. van IJckenf, Orazio J. Slivanob, Alan J. Burnsa,g, Christine K. Christieb, Karen L. de Mesy Bentleyh, Alice S. Brooksa, Dick Tibboeli, Suowen Xub, Zheng Gen Jinb, Tono Djuwantonoj, Wei Yanc, Maria M. Alvesa, Robert M. W. Hofstraa,g,2, and Joseph M. Mianob,2 aDepartment of Clinical Genetics, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands; bAab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642; cDepartment of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557; dDepartment of Genetics, University Medical Center, University of Groningen, 9700 RB Groningen, The Netherlands; eDepartment of Pathology, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands; fCenter for Biomics, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands; gStem Cells and Regenerative Medicine, Birth Defects Research Centre, University College London Institute of Child Health, London WC1N 1EH, United Kingdom; hDepartment of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642; iDepartment of Pediatric Surgery, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands; and jDepartment of Obstetrics and Gynecology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia Edited by Eric N. Olson, University of Texas Southwestern Medical Center, Dallas, TX, and approved February 21, 2017 (received for review December 13, 2016) Megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) is lacking (6, 7). -
Global MEF2 Target Gene Analysis In
Published online 12 September 2014 Nucleic Acids Research, 2014, Vol. 42, No. 18 11349–11362 doi: 10.1093/nar/gku813 Global MEF2 target gene analysis in cardiac and skeletal muscle reveals novel regulation of DUSP6 by p38MAPK-MEF2 signaling Stephanie Wales1,2,3, Sara Hashemi1,2,3, Alexandre Blais4 and John C. McDermott1,2,3,5,* 1Department of Biology, York University, 4700 Keele Street Toronto, Ontario, M3J 1P3 Canada, 2Muscle Health Research Centre (MHRC), York University, 4700 Keele Street, Toronto, Ontario, M3J 1P3 Canada, 3Centre for Research on Biomolecular Interactions (CRBI), 4700 Keele Street, Toronto, Ontario, M3J 1P3 Canada, 4Ottawa Institute of Systems Biology, University of Ottawa, Health Sciences Campus, 451 Smyth Road, Ottawa, Ontario, K1H 8M5 Canada and 5Centre for Research in Mass Spectrometry (CRMS), York University, 4700 Keele Street, Toronto, Ontario, M3J 1P3 Canada Downloaded from Received June 12, 2014; Revised August 23, 2014; Accepted August 28, 2014 ABSTRACT INTRODUCTION http://nar.oxfordjournals.org/ MEF2 plays a profound role in the regulation of tran- Myocyte enhancer factor-2 (MEF2) is a member of the scription in cardiac and skeletal muscle lineages. MADS-box super family of transcriptional regulatory pro- To define the overlapping and unique MEF2A ge- teins originally identified in skeletal muscle but are now nomic targets, we utilized ChIP-exo analysis of car- an established component in the regulation of a diverse diomyocytes and skeletal myoblasts. Of the 2783 and number of tissues, including smooth, cardiac and skele- tal muscle, neurons and T cells (1–4). In vertebrates 1648 MEF2A binding peaks in skeletal myoblasts and there are four MEF2 isoforms (A–D) which bind to the cardiomyocytes, respectively, 294 common binding consensus sequence (C/T TA(A/T)4TA G/A) within the sites were identified.